Neuron23 Inc. is a clinical-stage biotechnology company developing precision medicines for genetically defined neurological and immunological diseases. The company combines human genetics, drug discovery and biomarker platforms with machine learning and artificial intelligence to advance therapeutics for neurodegenerative, neuroinflammatory, and systemic autoimmune and inflammatory disorders.
Leadership & Board
Current Number of Employees29
Current LinkedIn Followers6,598
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$97M
Total Amount Raised$97M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$97M
Latest Funding Amount$97M
Latest Funding RoundSeries D
Latest Funding RoundSeries D
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Neuron23 had 29 employees as of September 7, 2026. The number of employees increased by 0 (0.00%) week-over-week.
29Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Neuron23 had 6,598 followers as of September 7, 2026. The number of followers increased by 7 (0.11%) week-over-week.
6,598Latest Followers Count
7(0.11%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jul 24, 2025
Series D
$96.50M
―
Similar Companies
A snapshot of private companies similar to Neuron23, helping you discover and navigate related company profiles.